November 15, 2023 02:18 PM EST

Ozempic shortages have European countries exploring bans on use of popular drug for weight loss

Katherine Lewin

News Reporter

Belgium banned the use of Novo Nordisk’s diabetes drug Ozempic for weight loss this week, and Germany is considering a similar action amid shortages of …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Ozempic shortages have European countries exploring bans on use of popular drug for weight loss

Katherine Lewin

News Reporter

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

BridgeBio shares promising results in trial of Canavan disease gene therapy

CRISPR therapy reduces swelling attacks by 81% in Intellia follow-up study

Facing lost rebates, MGM Resorts to stop covering GLP-1 weight loss shots

Icon's quarterly earnings hit by biotech and pharma pullback

Exclusive: University of Toronto spinout raises $53.5M to create new obesity drugs with AI

IDEAYA Biosciences: Targeting unmet market needs with precision oncology

Ozem­pic short­ages have Eu­ro­pean coun­tries ex­plor­ing bans on use of pop­u­lar drug for weight loss

News Reporter

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Ozempic shortages have European countries exploring bans on use of popular drug for weight loss